- NCIt
- C4407
Loading cancer entity…
Loading cancer entity…
Clinical trials
46 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06054178 | Identification of Nerves Using Fluorescein Sodium | completed | Phase 2 | 8 | Stanford UniversityOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT07185542 | Function-Preserving Surgery for Parotid Tumors: Intracapsular Versus Superficial Parotidectomy; A Randomized Clinical Trial. | completed | N/A | 120 | Al-Azhar UniversityOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT07028437 | The Effect of Endoscopy-assisted Transoral Parotid Gland Tumor Excision Compared With Traditional Operation | completed | N/A | 30 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jun 19, 2025 | clinicaltrials |
| NCT04420689 | Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery |
Data updated 22 days agoSource updated May 20, 2026source: clinicaltrials
| completed |
| Phase 1 / Phase 2 |
| 27 |
| Alume Biosciences, Inc.INDUSTRY |
| 1 |
| May 8, 2025 |
| clinicaltrials |
| NCT00405405 | Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer | completed | Phase 1 | 13 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT04028479 | The Registry of Oncology Outcomes Associated With Testing and Treatment(ROOT) | completed | — | 167 | Taproot HealthINDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT02538510 | Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery | completed | Phase 1 / Phase 2 | 50 | University of WashingtonOTHER | 1 | Nov 26, 2024 | clinicaltrials |
| NCT03749460 | Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers | completed | Phase 1 / Phase 2 | 20 | University of WashingtonOTHER | 1 | Dec 29, 2023 | clinicaltrials |
| NCT03822728 | Intra-parotid Facial Nerve Imaging in Parotidectomy | completed | N/A | 270 | Samsung Medical CenterOTHER | 1 | Nov 27, 2023 | clinicaltrials |
| NCT05152056 | MRI and Fine Needle Aspiration in the Diagnosis of Parotid Tumors(Parotid) | completed | — | 133 | University Hospital, Strasbourg, FranceOTHER | 1 | Dec 10, 2021 | clinicaltrials |
| NCT04803032 | Trident Landmark as a Safe and Easy Method for Facial Nerve Trunk Identification During Superficial Parotidectomy | completed | N/A | 60 | Kafrelsheikh UniversityOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT01175980 | Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 2 | Aug 3, 2020 | clinicaltrials |
| NCT01254617 | Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer(ADCC) | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Mar 13, 2020 | clinicaltrials |
| NCT04296266 | Human Salivary Gland Disposition of Alda-341 in Patients Undergoing Salivary Gland Surgery | completed | Early Phase 1 | 10 | Stanford UniversityOTHER | 1 | Mar 5, 2020 | clinicaltrials |
| NCT01604772 | Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma | completed | Phase 2 | 16 | National Cancer Institute (NCI)NIH | 1 | May 1, 2019 | clinicaltrials |
| NCT00859937 | Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 2 | Apr 20, 2018 | clinicaltrials |
| NCT01256385 | Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy(MAESTRO HN) | completed | Phase 2 | 86 | National Cancer Institute (NCI)NIH | 2 | Mar 27, 2017 | clinicaltrials |
| NCT02527226 | Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors | completed | N/A | 76 | Mayo ClinicOTHER | 1 | Sep 16, 2016 | clinicaltrials |
| NCT01731379 | Optical Detection of Peripheral Nerve Bundles During Surgery(NerveSpect) | completed | — | 35 | Philips HealthcareINDUSTRY | 1 | Nov 3, 2015 | clinicaltrials |
| NCT00458978 | Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer | completed | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | May 5, 2015 | clinicaltrials |
| NCT01983176 | Retrospective Clinical Outcome of Parotid Tumor Surgery | completed | — | 767 | National Taiwan University HospitalOTHER | 1 | Nov 26, 2013 | clinicaltrials |
| NCT01414790 | The Use of Human Acellular Dermal Matrix to Improve Infraauricular Depressed Deformities and Frey's Syndrome | completed | Phase 3 | 70 | West China HospitalOTHER | 1 | Aug 11, 2011 | clinicaltrials |